Cargando…
Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance
INTRODUCTION: Chemotherapy remains the only available treatment for triple-negative (TN) breast cancer, and most patients exhibit an incomplete pathologic response. Half of patients exhibiting an incomplete pathologic response die within five years of treatment due to chemo-resistant, recurrent tumo...
Autores principales: | Li, Shenduo, Payne, Sturgis, Wang, Fang, Claus, Peter, Su, Zuowei, Groth, Jeffrey, Geradts, Joseph, de Ridder, Gustaaf, Alvarez, Rebeca, Marcom, Paul Kelly, Pizzo, Salvatore V., Bachelder, Robin E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491247/ https://www.ncbi.nlm.nih.gov/pubmed/26141457 http://dx.doi.org/10.1186/s13058-015-0590-3 |
Ejemplares similares
-
Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface
por: Nelson, Erik R., et al.
Publicado: (2016) -
Adipose stem cell crosstalk with chemo-residual breast cancer cells: implications for tumor recurrence
por: Lyes, Matthew A., et al.
Publicado: (2018) -
Model of Tumor Dormancy/Recurrence after Short-Term Chemotherapy
por: Li, Shenduo, et al.
Publicado: (2014) -
Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells
por: Mo, Lihong, et al.
Publicado: (2015) -
Mechano-chemo signaling interactions modulate matrix production by cardiac fibroblasts
por: Rogers, Jesse D., et al.
Publicado: (2020)